A detailed history of Wellington Management Group LLP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 23,964,044 shares of FOLD stock, worth $236 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
23,964,044
Previous 21,107,943 13.53%
Holding current value
$236 Million
Previous $209 Million 22.23%
% of portfolio
0.05%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.55 - $12.09 $27.3 Million - $34.5 Million
2,856,101 Added 13.53%
23,964,044 $256 Million
Q2 2024

Aug 13, 2024

BUY
$9.04 - $11.75 $20.8 Million - $27.1 Million
2,304,298 Added 12.25%
21,107,943 $209 Million
Q1 2024

May 15, 2024

BUY
$11.43 - $14.24 $215 Million - $268 Million
18,803,645 New
18,803,645 $222 Million
Q4 2023

Feb 12, 2024

BUY
$9.97 - $14.52 $151 Million - $221 Million
15,190,024 New
15,190,024 $216 Million
Q3 2023

Nov 14, 2023

SELL
$11.78 - $13.86 $3.49 Million - $4.11 Million
-296,607 Reduced 3.79%
7,523,689 $91.5 Million
Q2 2023

Aug 14, 2023

BUY
$10.72 - $13.3 $3.27 Million - $4.06 Million
305,255 Added 4.06%
7,820,296 $98.2 Million
Q1 2023

May 12, 2023

SELL
$10.91 - $13.54 $6.46 Million - $8.02 Million
-592,306 Reduced 7.31%
7,515,041 $83.3 Million
Q4 2022

Feb 13, 2023

BUY
$9.89 - $12.7 $504,113 - $647,344
50,972 Added 0.63%
8,107,347 $99 Million
Q3 2022

Nov 14, 2022

SELL
$9.82 - $12.75 $29.1 Million - $37.8 Million
-2,968,369 Reduced 26.92%
8,056,375 $84.1 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $11.12 $97.2 Million - $173 Million
-15,594,363 Reduced 58.58%
11,024,744 $118 Million
Q1 2022

May 16, 2022

SELL
$7.89 - $12.48 $233,283 - $368,996
-29,567 Reduced 0.11%
26,619,107 $252 Million
Q4 2021

Feb 11, 2022

BUY
$9.82 - $12.44 $23.1 Million - $29.3 Million
2,352,976 Added 9.68%
26,648,674 $308 Million
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $75.4 Million - $102 Million
8,624,249 Added 55.03%
24,295,698 $232 Million
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $13.6 Million - $16.8 Million
1,563,477 Added 11.08%
15,671,449 $151 Million
Q1 2021

May 17, 2021

BUY
$9.2 - $23.86 $36.5 Million - $94.8 Million
3,971,505 Added 39.18%
14,107,972 $139 Million
Q4 2020

Feb 12, 2021

BUY
$13.47 - $24.89 $55.7 Million - $103 Million
4,133,312 Added 68.85%
10,136,467 $234 Million
Q3 2020

Nov 16, 2020

SELL
$12.89 - $15.89 $9.28 Million - $11.4 Million
-720,136 Reduced 10.71%
6,003,155 $84.8 Million
Q2 2020

Aug 14, 2020

BUY
$8.86 - $15.69 $18.1 Million - $32 Million
2,042,114 Added 43.62%
6,723,291 $101 Million
Q1 2020

May 14, 2020

SELL
$6.63 - $11.16 $2.3 Million - $3.87 Million
-347,164 Reduced 6.9%
4,681,177 $43.3 Million
Q4 2019

Feb 11, 2020

BUY
$7.48 - $10.75 $37.6 Million - $54.1 Million
5,028,341 New
5,028,341 $49 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.76B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.